References
- Salman MS. Epidemiology of Cerebellar Diseases and Therapeutic Approaches. Cerebellum. 2018;17(1):4-11.
- Boder E. Ataxia-telangiectasia: an overview. Kroc Found series. 1985; 19:1–63.
- van Os NJH, Jansen AFM, van Deuren M, Haraldsson A, et al. Ataxia-telangiectasia: immunodeficiency and survival. Clin Immunol 2017; 178:45–55.
- Craford TO, Skolasky RL, Fernandez R, et al. Survival probability in ataxia telangiectasia Arch Dis Child.2006; 91:610-611.
- Canman C, Lim DS. The role of ATM in DNA damage responses and cancer. Oncogene. 1998: 17:3301–3308
- Keene EJ. Diagnostic dental radiographs not allowed! A child with ataxia telangiectasia Eur Arch Paediatr Dent. 2014; 15:55–7.
- McGrath-Morow S, Lefton-Greif M, Rosquist K, et al. Pulmonary function in adolescents with ataxia telangiectasia. Pediatr Pulmonol. 2008; 43(1):59-66.
- Lockman JL, Iskander AJ, Bembea M, et al. Anesthetic and perioperative risk in the patient with Ataxia-Telangiectasia. Paediatr Anaesth. 2012; 22(3):256-262.
- Verhagen MM, Yntema JB, Weemaes CR, et al. Ataxia-Telangiectasia and mechanical ventilation: A word of caution. Pediatr. Pulmonol.2009; 44: 101-102.
- Boder E, Sedgwick RP. Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics. 1958; 21:526-554.
- Tadjoedin MK, Fraiser FC. Heredity of Ataxia-Telangiectasia (Louis-Bar Syndrome). Am J Dis Child.1965;110(1):64–68.
- Sedgwick RP, Border E (1972) Ataxia-telangiectasia. In: Vinken PJ, Bruyn GW (eds) Handbook of Clinical Neurology, Vol XIV, The Phakomatoses. American Elsevier, New York, p 267
- Centerwall WR, Miller MM. Ataxia, telangiectasia, and sinopulmonary infections. Amer.J. Dis.Child.1958;95:385-396.
- Gatti RA, Boder E, Vinters HV, Sparkes RS, Norman A, Lange K: Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Mean interdisciplinary approach to pathogenesis. Medicine.199; 70:99-117.
- Teive HA, Moro A, Moscovich M, Arruda WO, Munhoz RP, Raskin S, Ashizawa T. Ataxia-telangiectasia-A historical review and a proposal for a new designation: ATM syndrome. J Neurol Sci. 2015; 355:3–6. doi: 10.1016/j. jns.2015.05.022.
- Silver G, Mercimek-Andrews S. Inherited Metabolic Disorders Presenting with Ataxia. Int J Mol Sci. 2020 Aug 1;21(15):5519. doi: 10.3390/ijms21155519. PMID: 32752260; PMCID: PMC7432519.
- Hunt CR, Pandita RK, Laszlo A, et al. Hyper-thermia activates a subset of ataxia-telangiectasia mutated effectors independent of DNA strand breaks and heat shock protein 70 status. Cancer Res. 2007; 67(7):3010-7.
- Lockman JL, Iskander AJ, Bembea M, et al. The critically ill patient with ataxia–telangiectasia: A case series. Pediatric Critical Care Medicine. 2012:13(2): 84-90.
- Vecchio D, Frosina G. Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy. Curr Drug Targets. 2016;17(2):139-53
- Verhagen MM, Martin JJ, van Deuren M, et al. Neuropathology in classical and variant ataxia-telangiectasia. Neuropathology. 2012; 32(3):234-44.